Cardiology

 

The Endocrinology Network® Cardiology clinical resource center is a hub of news related to cardiovascular health that is relevant to clinicians interested in endocrinology. A leading cause of death among diabetics and a threat for many with other endocrine diseases, this page will host relevant content about cardiology and cardiovascular disease including guideline updates, new studies and breakthroughs, and clinical perspective for practicing clinicians.

Finerenone Provides Consistent Benefit, Irrespective of Background GLP-1 RA Use

June 26, 2021

A FIDELIO-DKD analysis presented at ADA 2021 suggests the renal and cardiovascular benefits of finerenone were consistent, irrespective of background GLP-1 RA use and indicate the presence of both was associated with even greater reductions in albuminuria.

Dapagliflozin Cuts Risk of Diabetes in Patients with Chronic Kidney Disease

June 25, 2021

A prespecified analysis of DAPA-CKD presented at ADA 2021 suggests use of dapagliflozin reduced the incidence of type 2 diabetes by nearly 40% among patients with chronic kidney disease but without diabetes within the phase 3 trial.

Finerenone and SGLT2 Inhibitors Could Have Additive Effect on Kidney Protection

June 25, 2021

Data from an analysis of FIDELIO-DKD suggests the renoprotective benefits of finerenone were consistent irrespective of SGLT2 inhibitor use and those using an SGLT2 inhibitor with finerenone resulted in greater UACR reductions.

Early Life BMI Plays Role in Future Diabetes and CVD Risk, Regardless of Adult BMI

June 22, 2021

Using 24 years of follow-up data from more than 12k adolescents provides insight into the impact of childhood BMI z-scores on risk of adverse health outcomes, including development of diabetes and premature myocardial infarction, in adulthood.

Older Adults with Diabetes Twice as Likely to Use Aspirin for Prevention

June 21, 2021

Using data from within NHANES from 2011-2018, investigators from Johns Hopkins University provide a comprehensive overview of the use of aspirin for primary and secondary prevention among older patients based on diabetes status.

Combination of Fish Oil and Metformin Could Help Alleviate Burden of Dyslipidemia in Young Women with Polycystic Ovary Syndrome

June 21, 2021

A pilot trial in 29 women suggests a combination of metformin and high dose fish oil could reduce triglycerides and ApoB-remnants among young women with polycystic ovary syndrome.

'Metabolically Healthy' Obesity Still Puts Patients at Increased Risk of Adverse Health Outcomes

June 14, 2021

Data from the UK Biobank cohort details the increased risk of adverse health outcomes, including the development of diabetes and heart failure, among patients considered to have metabolically healthy obesity.

Women with Polycystic Ovary Syndrome at Increased Risk of Cardiovascular Disease Events

June 10, 2021

A comparison of women with PCOS to matched controls indicates women with PCOS were at a 26% greater risk of experiencing major adverse cardiovascular events than their counterparts without polycystic ovary syndrome.

Despite Advances, Rates of Glycemic Control Backsliding in Past Decade

June 09, 2021

A cross-sectional analysis of NHANES data paints a grim picture related to rates of patients with diabetes achieving goals for glycemic, blood pressure, and lipid control.

Study Underlines Importance of Quality Sleep in Patients with Diabetes

June 08, 2021

An analysis of data from nearly 500k patients suggests patients with diabetes experiencing frequent insomnia were at an 87% increased risk of all-cause mortality compared to those with neither sleep disturbances nor diabetes.